IRIS
CENTONZE, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 149.894
AS - Asia 19.606
EU - Europa 14.028
SA - Sud America 2.603
Continente sconosciuto - Info sul continente non disponibili 1.890
AF - Africa 242
OC - Oceania 56
AN - Antartide 1
Totale 188.320
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 149.118
SG - Singapore 9.057
CN - Cina 3.495
IT - Italia 2.857
BR - Brasile 2.132
HK - Hong Kong 1.932
RU - Federazione Russa 1.895
UA - Ucraina 1.819
DE - Germania 1.688
KR - Corea 1.544
IE - Irlanda 1.470
VN - Vietnam 1.281
GB - Regno Unito 863
FR - Francia 842
BD - Bangladesh 742
SE - Svezia 684
FI - Finlandia 544
JP - Giappone 476
CA - Canada 400
PL - Polonia 370
NL - Olanda 328
IN - India 252
AR - Argentina 164
ID - Indonesia 132
ES - Italia 112
MX - Messico 111
TR - Turchia 104
IQ - Iraq 98
ZA - Sudafrica 86
AT - Austria 85
EC - Ecuador 70
BE - Belgio 64
CZ - Repubblica Ceca 64
CO - Colombia 60
JM - Giamaica 60
CL - Cile 52
UZ - Uzbekistan 52
RO - Romania 51
EU - Europa 50
AU - Australia 47
CR - Costa Rica 45
PH - Filippine 41
MY - Malesia 40
IR - Iran 39
SA - Arabia Saudita 39
BG - Bulgaria 36
MA - Marocco 34
PY - Paraguay 34
VE - Venezuela 34
LT - Lituania 33
CH - Svizzera 29
PK - Pakistan 28
AE - Emirati Arabi Uniti 26
KE - Kenya 25
DK - Danimarca 24
GR - Grecia 24
UY - Uruguay 23
GT - Guatemala 22
HN - Honduras 22
KG - Kirghizistan 22
NG - Nigeria 21
NP - Nepal 21
PE - Perù 21
TN - Tunisia 20
AL - Albania 19
EG - Egitto 19
PT - Portogallo 19
IL - Israele 18
TT - Trinidad e Tobago 18
JO - Giordania 17
TW - Taiwan 17
DM - Dominica 16
EE - Estonia 16
HR - Croazia 16
KZ - Kazakistan 16
NI - Nicaragua 16
TH - Thailandia 16
DO - Repubblica Dominicana 15
DZ - Algeria 15
RS - Serbia 15
AZ - Azerbaigian 13
OM - Oman 12
LB - Libano 11
NO - Norvegia 11
PR - Porto Rico 11
BO - Bolivia 10
SV - El Salvador 10
SI - Slovenia 9
BB - Barbados 8
HU - Ungheria 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BH - Bahrain 7
CY - Cipro 7
KH - Cambogia 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
BN - Brunei Darussalam 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
AM - Armenia 5
Totale 186.390
Salva come PNG Salva come JPEG
Città #
Woodbridge 39.299
Wilmington 37.939
Houston 32.869
Fairfield 4.471
Singapore 4.068
Ashburn 3.396
Ann Arbor 3.273
San Jose 2.457
Hong Kong 1.891
Seattle 1.810
Chandler 1.739
Jacksonville 1.609
Cambridge 1.529
Dublin 1.420
Beijing 1.119
Medford 1.025
Council Bluffs 851
New York 756
Santa Clara 739
The Dalles 720
Rome 618
Dearborn 561
Los Angeles 520
Lawrence 486
Dallas 423
Ho Chi Minh City 406
Tokyo 400
Buffalo 383
Zhengzhou 351
Hanoi 282
Hangzhou 277
Kraków 273
Moscow 259
Lauterbourg 245
Mülheim 241
San Diego 240
Milan 236
São Paulo 222
Menlo Park 199
Norwalk 173
Munich 159
Orem 153
Chicago 151
London 143
Atlanta 119
Redwood City 107
Helsinki 102
Shanghai 102
Denver 101
Toronto 97
Guangzhou 96
Brooklyn 95
Montreal 90
San Mateo 86
Lappeenranta 85
Frankfurt am Main 84
North Bergen 84
Nuremberg 83
Redondo Beach 83
Mountain View 80
Naples 79
Chennai 78
University Park 78
Jakarta 74
Phoenix 74
Falls Church 71
San Francisco 69
Rio de Janeiro 66
Seoul 65
Warsaw 65
Verona 63
Detroit 62
Saint Petersburg 60
Philadelphia 59
Columbus 57
Amsterdam 56
Brussels 56
Hefei 56
Nanjing 56
Palo Alto 55
Manchester 52
Salt Lake City 52
Boardman 51
Johannesburg 50
Belo Horizonte 49
Boston 48
Brno 46
Colorado Springs 46
Haiphong 46
Stockholm 46
Florence 45
Mcallen 45
Brasília 44
Da Nang 41
Miami 40
Charlotte 39
Kingston 39
Tashkent 37
Vienna 37
Kunming 36
Totale 154.063
Salva come PNG Salva come JPEG
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 744
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 681
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 627
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 619
TRPV1 channels facilitate glutamate transmission in the striatum 616
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 615
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 612
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma 603
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 595
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 589
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 588
Neurophysiology of synaptic functioning in multiple sclerosis 581
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 564
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 561
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis 545
Effects of postural exercises in patients with Parkinson's disease and Pisa syndrome: A pilot study 545
The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis 541
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 540
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 539
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 537
KFLC Index utility in multiple sclerosis diagnosis: Further confirmation 534
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 532
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 531
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 529
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 528
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 528
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients 528
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 520
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 518
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy 514
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 514
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 513
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 513
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 507
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 506
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 500
TRPV1 channels regulate cortical excitability in humans 500
Synaptic transmission in the striatum: from plasticity to neurodegeneration 494
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 494
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 493
Subclinical central inflammation is risk for RIS and CIS conversion to MS 491
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 490
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 490
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 490
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 490
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 488
Abnormal brain lateralization and connectivity in schizophrenia 487
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 486
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes 486
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 485
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 484
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 483
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 483
Muscarinic IPSPs in rat striatal cholinergic interneurones 482
Treatment decisions for patients with active multiple sclerosis 482
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 481
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 480
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 479
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 479
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis 478
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 478
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 477
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 477
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 477
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 476
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 476
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 475
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 475
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 474
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 474
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 473
A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum 472
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 472
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis 471
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 471
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 471
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 471
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 470
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 470
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 470
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801 469
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 469
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 469
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 468
Disability in multiple sclerosis: When synaptic long-term potentiation fails 468
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 467
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes 467
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 466
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis 466
D-aspartate: an atypical amino acid with neuromodulatory activity in mammals 466
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 465
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals 464
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 463
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis 463
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 463
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis 462
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 462
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 461
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 460
Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis 459
Totale 50.599
Salva come PNG Salva come JPEG
Categoria #
all - tutte 454.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 454.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.013 0 0 0 239 107 671 203 201 427 541 219 1.405
2022/20235.738 745 376 290 610 344 1.499 546 291 395 41 446 155
2023/20241.872 259 72 135 110 161 433 156 98 34 64 33 317
2024/202513.492 356 2.704 1.245 654 477 1.041 1.003 507 1.040 1.084 1.894 1.487
2025/202620.387 1.509 1.076 2.284 1.299 2.034 617 2.476 2.484 2.393 2.015 1.163 1.037
2026/20277.252 1.110 1.159 3.885 1.098 0 0 0 0 0 0 0 0
Totale 188.320